426 related articles for article (PubMed ID: 18471934)
1. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
Wilczak N; Chesik D; Hoekstra D; De Keyser J
Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
[TBL] [Abstract][Full Text] [Related]
2. Why does remyelination fail in multiple sclerosis?
Franklin RJ
Nat Rev Neurosci; 2002 Sep; 3(9):705-14. PubMed ID: 12209119
[TBL] [Abstract][Full Text] [Related]
3. The insulin-like growth factor system in multiple sclerosis.
Chesik D; Wilczak N; De Keyser J
Int Rev Neurobiol; 2007; 79():203-26. PubMed ID: 17531843
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis?
Maier O; van der Heide T; van Dam AM; Baron W; de Vries H; Hoekstra D
Mol Cell Neurosci; 2005 Feb; 28(2):390-401. PubMed ID: 15691718
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factors and binding proteins in multiple sclerosis plaques.
Gveric D; Cuzner ML; Newcombe J
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):215-25. PubMed ID: 10417663
[TBL] [Abstract][Full Text] [Related]
7. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
Vana AC; Lucchinetti CF; Le TQ; Armstrong RC
Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2.
Padovani-Claudio DA; Liu L; Ransohoff RM; Miller RH
Glia; 2006 Oct; 54(5):471-83. PubMed ID: 16886211
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions.
Itoyama Y; Sternberger NH; Webster HD; Quarles RH; Cohen SR; Richardson EP
Ann Neurol; 1980 Feb; 7(2):167-77. PubMed ID: 6154440
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocytes in the early course of multiple sclerosis.
Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
[TBL] [Abstract][Full Text] [Related]
12. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro.
Kühl NM; De Keyser J; De Vries H; Hoekstra D
J Neurosci Res; 2002 Jul; 69(2):207-16. PubMed ID: 12111802
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis.
Chesik D; De Keyser J; Wilczak N
Cytokine Growth Factor Rev; 2007; 18(3-4):267-78. PubMed ID: 17485236
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
Raine CS; Scheinberg L; Waltz JM
Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
[TBL] [Abstract][Full Text] [Related]
16. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
Mastronardi FG; Moscarello MA
J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
Sinclair C; Mirakhur M; Kirk J; Farrell M; McQuaid S
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells.
Chesik D; De Keyser J; Glazenburg L; Wilczak N
Eur J Neurosci; 2006 Sep; 24(6):1645-52. PubMed ID: 17004928
[TBL] [Abstract][Full Text] [Related]
19. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
Chang A; Tourtellotte WW; Rudick R; Trapp BD
N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
[TBL] [Abstract][Full Text] [Related]
20. Remyelination capacity of the MS brain decreases with disease chronicity.
Goldschmidt T; Antel J; König FB; Brück W; Kuhlmann T
Neurology; 2009 Jun; 72(22):1914-21. PubMed ID: 19487649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
